Basic Science and Pathogenesis

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• The APOE ε4 allele is a major genetic risk factor for Alzheimer's disease (AD).
• Amylin, elevated in AD patients, forms neurotoxic amyloid plaques with β-amyloid (Aβ).
• Previous studies showed amylin binds apolipoproteins and disrupts Aβ efflux.

Purpose of the Study:

• To test if apoE-amylin molecular complexes provoke apoE4-associated neuropathology in AD.
• To investigate the role of apoE isoforms in amylin-induced brain pathology.
• To determine if amylin-apoE complexes impact Aβ accumulation.

Main Methods:

• Generated transgenic mice expressing human amylin and apoE3 or apoE4 (E3HIP, E4HIP), or apoE-knockout with amylin (EKO-HIP).
• Conducted behavioral tests and analyzed brain tissue using immunoprecipitation, ELISAs, and proximity ligation assays (PLAs).
• Utilized mice with human apoE and mouse amylin as negative controls.

Main Results:

• E4HIP mice exhibited reduced recognition memory and significantly increased parenchymal amylin and Aβ compared to E3HIP and EKO-HIP mice.
• Immunoprecipitation revealed apoE isoform-dependent affinities for amylin.
• PLAs confirmed robust colocalization of amylin-apoE complexes in E3HIP and E4HIP mouse brains.

Conclusions:

• Human amylin forms parenchymal complexes with apoE, worsening Aβ pathology, especially in apoE4⁺ mice.
• ApoE acts as a molecular carrier for amylin and Aβ at the blood-brain barrier.
• Differential apoE-amylin interaction strengths may contribute to apoE4-associated AD neuropathology.